Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification
News Mar 28, 2006
Geneservice Ltd has announced that the Wellcome Trust Sanger Institute has chosen Geneservice to provide whole genome amplification for circa 25,000 samples from multiple studies including the Wellcome Trust Case Control Consortium (WTCCC), EPIC (obesity), MalariaGen, and the International 1q type 2 diabetes consortium.
Expanding the amount of DNA available will allow multiple future experiments on these samples that have been collected over many years.
Evaluation of suppliers, was based on a common set of samples tested post-amplification with the Affymetrix™ Genechip as well as Illumina Golden Gate and Infinium technologies.
The selection of Geneservice was based on a combination of responsiveness, performance, quality of service and value for money.
Tom Weaver, CEO of Geneservice commented, "I am delighted that we have been awarded this prestigious project against strong international competition. Working with world class scientific teams and being entrusted to amplify their samples is a tribute to the dedicated Geneservice team."
Panos Deloukas of the Wellcome Trust Sanger Institute added, "We looked for a provider to work closely with us to develop robust protocols for these important projects."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE